NT5E and colorectal cancer: Additionally, Lian et al. [59] reported higher CD73 expression levels in mismatch repair-deficient tumors compared to MMR-proficient cases, suggesting that CD73+ B lymphocytes may contribute to reduced responsiveness to immunotherapy in certain colorectal cancer subtypes.